RBCL (RBC Life Sciences) Accumulated Depreciation: $-2.39 Mil (As of Jun. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is RBC Life Sciences Accumulated Depreciation?

RBC Life Sciences RBCL Accumulated Depreciation is $-2.39 Mil as of Jun. 2017.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

RBC Life Sciences's quarterly accumulated depreciation increased from Dec. 2016 ($-2.23 Mil) to Mar. 2017 ($-2.32 Mil) and increased from Mar. 2017 ($-2.32 Mil) to Jun. 2017 ($-2.39 Mil).

RBC Life Sciences's annual accumulated depreciation declined from Dec. 2014 ($-4.31 Mil) to Dec. 2015 ($-1.82 Mil) but then increased from Dec. 2015 ($-1.82 Mil) to Dec. 2016 ($-2.23 Mil).

RBC Life Sciences Accumulated Depreciation Related Terms

RBC Life Sciences Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for RBC Life Sciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Life Sciences Accumulated Depreciation Chart

RBC Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.16 -3.75 -4.31 -1.82 -2.23

RBC Life Sciences Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.05 -2.15 -2.23 -2.32 -2.39

RBC Life Sciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-2.39 Mil mean?
RBC Life Sciences (RBCL) has a Accumulated Depreciation of $-2.39 Mil as of Jun. 2017. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' Accumulated Depreciation too high?
RBC Life Sciences' current Accumulated Depreciation is $-2.39 Mil.
How does RBC Life Sciences' Accumulated Depreciation compare to SKVI and TISUQ?
RBC Life Sciences' Accumulated Depreciation of $-2.39 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Consumer Packaged Goods company?
A good Accumulated Depreciation depends on the Consumer Packaged Goods industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on RBC Life Sciences and its competitors. RBC Life Sciences's current Accumulated Depreciation is $-2.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Accumulated Depreciation of $-2.39 Mil. The current Accumulated Depreciation is $-2.39 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Accumulated Depreciation is $-2.39 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.